Kleanthis Xanthopoulos

Kleanthis Xanthopoulos

Director/Board Member en CONNECT BIOPHARMA HOLDINGS LIMITED .

Fortuna: - $ al 31/03/2024

66 años
Health Technology
Commercial Services
Finance

Perfil

Kleanthis G.
Xanthopoulos
is the founder of Anadys Pharmaceuticals, Inc. (founded in 1992) and SENTÉ, Inc. (California) (founded in 2007).
He is also the founder of SENTÉ Labs (founded in 2007).
Dr. Xanthopoulos is also the founder of Shoreline Biosciences, Inc. Dr. Xanthopoulos's current job(s) include Chairman at Stork Capital SARL (since 2020), Director at Irras AB (since 2015), Director at Suzhou Connect Biopharma Co. Ltd.
(since 2020), Lead Independent Director at Connect Biopharma Holdings Ltd.
(since 2020), President at Helios, Inc., Member-Executive Board at BIOCOM, and Managing Partner at Vandel Group LLC.
Dr. Xanthopoulos's former job(s) include President, Chief Executive Officer & Director at Regulus Therapeutics, Inc. (2007-2015), Chairman at Apricus Biosciences, Inc. (2011-2019), Chairman at Bioniz Therapeutics, Inc. (2015-2016), Director at ZP Opco, Inc., Director at Biotechnology Innovation Organization, Director at J.E.M.
Capital, Inc. (2013-2014), Managing Director at Enterprise Partners Venture Capital (2007), Director at Odyssey Thera, Inc., Director at Aspirus, Inc., Director at Laboratori Derivati Organici SpA (2016-2017), Independent Director at Zosano Pharma Corp.
(2013-2021), Senior Vice President at Ionis Pharmaceuticals, Inc., Vice President-Genomics & Molecular Biology at Aurora Biosciences Corp.
(1997-2000), Associate Professor at Karolinska Institutet, Section Head at National Human Genome Research Institute (1995-1997), and Managing General Partner at Cerus Advisors DMCC (2015-2020).
Dr. Xanthopoulos's education includes a doctorate degree from the University of Stockholm (1986), a graduate degree from the University of Stockholm (1982), and an undergraduate degree from Aristotle University of Thessaloniki (1980).

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
01/03/2023 0 ( -.--% ) - $ 31/03/2024

Cargos activos de Kleanthis Xanthopoulos

EmpresasCargoInicio
IRRAS AB Director/Board Member 01/06/2015
CONNECT BIOPHARMA HOLDINGS LIMITED Director/Board Member 01/12/2020
Stork Capital SARL Chairman 01/06/2020
Director/Board Member 01/11/2020
Chief Executive Officer -
President -
Vandel Group LLC Corporate Officer/Principal -
Founder 01/01/2007
Corporate Officer/Principal 29/07/2014
░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░
Todos los cargos activos de Kleanthis Xanthopoulos

Antiguos cargos conocidos de Kleanthis Xanthopoulos.

EmpresasCargoFin
░░░░░░ ░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
Ver el detalle de la experiencia de Kleanthis Xanthopoulos.

Formación de Kleanthis Xanthopoulos.

University of Stockholm Graduate Degree
Aristotle University of Thessaloniki Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Kleanthis Xanthopoulos.

Relaciones

100 +

Relaciones de 1er grado

29

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas4
IONIS PHARMACEUTICALS, INC.

Health Technology

REGULUS THERAPEUTICS INC.

Health Technology

IRRAS AB

Health Technology

CONNECT BIOPHARMA HOLDINGS LIMITED

Health Technology

Empresas privadas22

Health Technology

Health Technology

Electronic Technology

Health Technology

Health Technology

Commercial Services

Finance

Commercial Services

Finance

Health Technology

Commercial Services

Health Services

Health Technology

Government

Retail Trade

Vandel Group LLC

Finance

Health Technology

Stork Capital SARL

Health Technology

SENTÉ Labs

Health Technology

Ver las conexiones de la empresa
  1. Bolsa de valores
  2. Insiders
  3. Kleanthis Xanthopoulos